Boston Scientific price target raised to $122 from $119 at Raymond James
Raymond James analyst Jayson Bedford raised the firm’s price target on Boston Scientific (BSX) to $122 from $119 and keeps a Strong Buy rating ...
Boston Scientific price target raised to $122 from $107 at Citi
Citi raised the firm’s price target on Boston Scientific (BSX) to $122 from $107 and keeps a Buy rating on the shares. The company reported ...
News Medical26d
Boston Scientific announces agreement to acquire Bolt Medical, Inc.
Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...